ofatumumab  - Drug Details
📊 Estimates ofatumumab  Dialyzability By Different_Modalities

ofatumumab 

Complete Drug Information

Drug Name
ofatumumab 
Trade Names
Arzerra, Kesimpta
Pregnancy Category
AU: C
Routes of Administration
Intravenous (Arzerra), subcutaneous (Kesimpta)
Elimination
14 days
Formula
C6480H10022N1742O2020S44
Molar Mass
146062.27
Volume of Distribution
1.7 L/kg

🤰 Pregnancy Category Information

Category: AU: C

Drugs which, owing to their pharmacological effects, have caused or may be suspected of causing harmful effects on the human fetus or neonate without causing malformations. These effects may be reversible.